Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a meta-analysis with the FREEDOM cardiovascular outcomes trial - Lee, MMY; Kristensen, SL; Gerstein, HC (Diabetes Metab Syndr, 2022)
et al.